These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11456041)

  • 1. Safe and effective use of chromatographically purified intravenous immunoglobulin despite profound anti-IgA sensitization.
    Limaye S; Walls RS; Riminton S
    Intern Med J; 2001; 31(4):256-7. PubMed ID: 11456041
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful gamma globulin therapy in a patient with anti-IgA antibodies].
    Litzman J; Broz P; Král V; Lokaj J
    Vnitr Lek; 1997 Feb; 43(2):102-4. PubMed ID: 9245064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of total variable immunodeficiency].
    Sennikova IuA; Stavrostina NM; Solovi'eva NIu; Sennikov SV; Shirinskiĭ VS; Kozlov VA
    Klin Med (Mosk); 2000; 78(12):57-60. PubMed ID: 11210358
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies.
    Cunningham-Rundles C; Zhou Z; Mankarious S; Courter S
    J Clin Immunol; 1993 Jul; 13(4):272-8. PubMed ID: 8227286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy.
    de Albuquerque Campos R; Sato MN; da Silva Duarte AJ
    J Clin Immunol; 2000 Jan; 20(1):77-82. PubMed ID: 10798611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor and intravenous gammaglobulins in common variable immunodeficiency.
    Farber CM; Crusiaux A; Schandené L; van Vooren JP; Goldman M; Dupont E; Tasiaux N
    Clin Immunol Immunopathol; 1994 Aug; 72(2):233-6. PubMed ID: 8050197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of FCRN expression on lung decline and intravenous immunoglobulin catabolism in common variable immunodeficiency patients.
    Litzman J
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):103-4. PubMed ID: 25546780
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of ulcerative and diabeticorum necrobiosis lipoidica with intravenous immunoglobulin in a patient with common variable immunodeficiency.
    Barouti N; Cao AQ; Ferrara D; Prins C
    JAMA Dermatol; 2013 Jul; 149(7):879-81. PubMed ID: 23864091
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay.
    Salama A; Schwind P; Schönhage K; Genth R; Cotting C; Hustinx H; Krieg R; Nydegger U; Aebischer I
    Vox Sang; 2001 Jul; 81(1):45-8. PubMed ID: 11520416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a common variable immunodeficiency in IgA-deficient patients.
    Español T; Catala M; Hernandez M; Caragol I; Bertran JM
    Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 1):333-5. PubMed ID: 8811056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variable immune deficiency and treatment with intravenous immunoglobulin during pregnancy.
    Brinker KA; Silk HJ
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):464-5. PubMed ID: 22626605
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukocytoclastic vasculitis and common variable immunodeficiency: successful treatment with intravenous immune globulin.
    Sais G; Vidaller A; Servitje O; Jucglà A; Peyrí J
    J Allergy Clin Immunol; 1996 Jul; 98(1):232-3. PubMed ID: 8765839
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy.
    Horn J; Thon V; Bartonkova D; Salzer U; Warnatz K; Schlesier M; Peter HH; Grimbacher B
    Clin Immunol; 2007 Feb; 122(2):156-62. PubMed ID: 17137841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of intravenous immunoglobulin treatment.
    Caress JB; Kennedy BL; Eickman KD
    Expert Opin Drug Saf; 2010 Nov; 9(6):971-9. PubMed ID: 20408737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy.
    Eijkhout HW; van den Broek PJ; van der Meer JW
    Neth J Med; 2003 Jun; 61(6):213-7. PubMed ID: 12948165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration.
    Danieli MG; Moretti R; Pettinari L; Gambini S
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23257273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Common variable immunodeficiency in an atopic patient with asthmatic manifestations].
    Bindi M; Quartieri F; Del Corso I; Sconosciuto F
    Recenti Prog Med; 1997 Dec; 88(12):588-9. PubMed ID: 9522602
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is there any clinical significance to anti-IgA antibodies which appear in patients with immunodeficiencies treated with intravenous gamma globulin?].
    Ferreira A; Cruz García Rodríguez M; Martín J; Fontán G
    Sangre (Barc); 1995 Jun; 40(3):171-3. PubMed ID: 7570266
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.
    Hasegawa M; Sakai F; Okabayashi A; Sato A; Yokohori N; Katsura H; Asano C; Kamata T; Koh E; Sekine Y; Hiroshima K; Ogura T; Takemura T
    Intern Med; 2017 Nov; 56(21):2899-2902. PubMed ID: 28924106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin.
    Danieli MG; Gelardi C; Pedini V; Gabrielli A
    Isr Med Assoc J; 2018 Dec; 20(12):782-783. PubMed ID: 30550011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.